SCH 28080 is a lumenally acting, K+-site inhibitor of the gastric (H+ + K+)-ATPase.

作者: David J. Keeling , Shiona M. Laing , Jorg Senn-Bilfinger

DOI: 10.1016/0006-2952(88)90586-2

关键词: Parietal cellWeak baseStereochemistryH(+)-K(+)-Exchanging ATPaseVesicleEnzymeATPaseExtracellularChemistryDephosphorylation

摘要: SCH 28080 (2-methyl-8-(phenylmethoxy)imidazo[1,2-a]pyridine-3-acetonitrile) is an effective inhibitor of acid secretion in vivo and a reversible, K+-competitive the gastric (H+ + K+)-ATPase vitro. The actions have been studied on vesicle preparations containing K+)-ATPase. At pH 7, inhibition was competitive with respect to K+ for both ATPase (Ki = 24 nM) pNPPase 275 activities. A close analogue (methylated 1-N position), that not expected cross membranes freely, inhibited activity less effectively intact preparations, where lumenal (extracellular) face membrane directly accessible. This suggested enzyme activities at site enzyme. Being protonatable weak base (pKa 5.6), would be accumulate lumenal, acidic side parietal cell its protonated form. potency 28080, relative “non-protonatable” analogue, increased low pH, commensurate proportion Thus accumulating form active inhibitory species. SCH (50 blocked rapid, K+-stimulated dephosphorylation catalytic phosphoenzyme intermediate room temperature. 4°, higher concentrations were required, suggesting rate binding slow temperatures.

参考文章(16)
P J Chiu, C Casciano, J F Long, G Tetzloff, A Barnett, Studies on the mechanisms of the antisecretory and cytoprotective actions of SCH 28080. Journal of Pharmacology and Experimental Therapeutics. ,vol. 226, pp. 121- 125 ,(1983)
B. Wallmark, C. Briving, J. Fryklund, K. Munson, R. Jackson, J. Mendlein, E. Rabon, G. Sachs, Inhibition of gastric H+,K+-ATPase and acid secretion by SCH 28080, a substituted pyridyl(1,2a)imidazole. Journal of Biological Chemistry. ,vol. 262, pp. 2077- 2084 ,(1987) , 10.1016/S0021-9258(18)61620-5
B. Wallmark, H.B. Stewart, E. Rabon, G. Saccomani, G. Sachs, The catalytic cycle of gastric (H+ + K+)-ATPase. Journal of Biological Chemistry. ,vol. 255, pp. 5313- 5319 ,(1980) , 10.1016/S0021-9258(19)70788-1
Jyotirmoy Nandi, Mark V. Wright, Tushar K. Ray, Mechanism of gastric antisecretory effects of nolinium bromide Gastroenterology. ,vol. 85, pp. 938- 945 ,(1983) , 10.1016/0016-5085(83)90447-X
David J. Keeling, Colin Fallowfield, Kevin J. Milliner, Stephen K. Tingley, Robert J. Ife, Anthony H. Underwood, Studies on the mechanism of action of omeprazole. Biochemical Pharmacology. ,vol. 34, pp. 2967- 2973 ,(1985) , 10.1016/0006-2952(85)90023-1
Hon-Cheung Lee, Haim Breitbart, Marcia Berman, John G. Forte, Potassium-stimulated ATPase activity and hydrogen transport in gastric microsomal vesicles Biochimica et Biophysica Acta (BBA) - Biomembranes. ,vol. 553, pp. 107- 131 ,(1979) , 10.1016/0005-2736(79)90034-8
Björn Wallmark, Arne Brändström, Håkan Larsson, Evidence for acid-induced transformation of omeprazole into an active inhibitor of (H+ + K+)-ATPase within the parietal cell Biochimica et Biophysica Acta (BBA) - Biomembranes. ,vol. 778, pp. 549- 558 ,(1984) , 10.1016/0005-2736(84)90406-1
Atsunobu Yoda, Lowell E. Hokin, On the reversibility of binding of cardiotonic steroids to a partially purified (Na + K)-activated adenosinetriphosphatase from beef brain Biochemical and Biophysical Research Communications. ,vol. 40, pp. 880- 886 ,(1970) , 10.1016/0006-291X(70)90985-X